Rechallenge of oxaliplatin-containing regimens in the third- or later-line therapy for patients with heavily treated metastatic colorectal cancer

PURPOSE: The third- or later-line therapy available often yield poor survival benefit in patients metastatic colorectal cancer (mCRC). The retrospective study aimed to evaluate efficacy of rechallenge of oxaliplatin-containing regimens. PATIENTS AND METHODS: Patients with mCRC who progressed from fl...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Onco Targets Ther
Main Authors: Yang, Qiong, Huang, Yuanyuan, Jiang, Zhimin, Wang, Huizhong, Li, Weiyu, Zhang, Bei, Xie, Derong
Formato: Artigo
Idioma:Inglês
Publicado em: Dove Medical Press 2018
Assuntos:
Original Research
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5937494/
https://ncbi.nlm.nih.gov/pubmed/29760556
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/OTT.S154220
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados